Adverse Overall Survival Impact of PD-L1 Positivity in Patients With KRAS G12C Mutation Is Abolished by the Immunotherapy Letter

cited authors

  • Yu, James; Du, Yuan; Mekhail, Tarek; Socinski, Mark A.; Chang, Chung-Che

authors

Publication Date

  • November 1, 2021

webpage

published in

category

keywords

  • Immunotherapy
  • KRAS subtypes
  • Molecular profiling
  • Non-small cell lung cancer
  • PD-L1 positivity

start page

  • E856

end page

  • E858

volume

  • 22

issue

  • 6